- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
Biopharmaceutical company Seaport Therapeutics announced the appointment of Lana Gladstein as general counsel.
Most recently, Gladstein was the group general counsel at APRINOIA Therapeutics. Her prior roles include chief legal officer at Recipharm; chief legal officer and general counsel at Arranta Bio; and executive vice president, general counsel, and officer at Brammer Bio.
Compliance Week accepts outside contributions from corporate chief compliance officers and other senior-level GRC practitioners. To learn more, contact the CW Editor.
Three former executives of Chicago-based Outcome Health, a healthcare technology company, were sentenced for misleading an auditor, clients, lenders, and investors about a scheme to sell $45 million in overbilled advertisements.
The U.S. Supreme Court extended the statute of limitations for businesses attempting to challenge some federal regulations, allowing regulated entities a longer timeline to appeal a decision.
A home health company operating in Indiana, Ohio, and Texas agreed to pay nearly $4.5 million to settle allegations it filed false claims by giving sports tickets and other kickbacks to assisted living facilities in exchange for referrals.
No comments yet